Jerusalem, Israel

Eli Breuer


 

Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 1993-2015

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Eli Breuer: Innovator in Metalloproteinase Inhibitors

Introduction

Eli Breuer is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of metalloproteinase inhibitors. With a total of 8 patents to his name, Breuer's work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents, Breuer has developed novel carbamoylphosphonates as inhibitors. This invention relates to unique metalloproteinase inhibitors that feature an aryloxybenzenesulfonamide moiety and a carbamoylphosphonic acid moiety. These compounds are designed for use in pharmaceutical compositions aimed at preventing or treating diseases associated with matrix metalloproteinases (MMP). Another significant patent involves compositions comprising oxophosphonate-based metalloproteinase inhibitors. This invention focuses on treating or controlling disease states linked to zinc-containing proteinases, particularly metalloproteinases. The active ingredients in these compositions include alpha-oxo- or alpha-thioxophosphonates, some of which are newly discovered compounds.

Career Highlights

Eli Breuer is affiliated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to explore innovative solutions in the pharmaceutical field. Breuer's research has garnered attention for its potential applications in medical treatments.

Collaborations

Throughout his career, Breuer has collaborated with notable colleagues, including Gershon Golomb and Reuven Reich. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Eli Breuer stands out as a key figure in the realm of pharmaceutical innovation, particularly in the development of metalloproteinase inhibitors. His contributions are paving the way for new therapeutic options in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…